Eight healthy male volunteers received 1 g of either ceftazidime or cefamandole as an intravenous injection. Serial blood samples were taken over the next 8 h. Urine samples were collected over 24 h. Levels of these antibiotics were measured in the fluid of blisters resulting from application of cantharides. The concentration of ceftazidime in serum at 0.25 h after intravenous injection was 83.3 4g/ml. The serum half-lives for the respective drugs were 1.8 and 0.8 h. The mean apparent volume of distribution of ceftazidime (13.6 liters) was greater than that of cefamandole (9.8 liters). Plasma clearance was 111 ml/min for ceftazidime and 216 ml/min for cefamandole. The maximum blister fluid concentration of ceftazidime was 45.9 tig/ml, and that of cefamandole was 22.1 4g/ml. The relative availability of each drug in blister fluid compared with serum was similar.
Ceftazidime (GR 20263) is a new broad-spectrum cephalosporin at present undergoing clinical evaluation (4, 6) . When administered parenterally to humans, it attains high levels in serum with no evidence of metabolic breakdown and has a somewhat longer half-life than do certain other clinically available cephalosporins (4) . This study provides a comparison of the pharmacokinetics of ceftazidime and cefamandole in healthy male volunteers and a comparison of the penetration of blister tissue fluid by these drugs. MATERIALS DISCUSSION The serum half-life of cefamandole has been reported to be 0.6 h after intravenous infusion and 1.0 h after intramuscular injection (2) , whereas in this study, the half-life was found to be 0.8 h. The difference is possibly due to differences in the technique of deriving the half-life, since these workers used a single-compartment model. The urinary recovery of cefamandole was similar to that found in an earlier study (2) .
The serum half-life of ceftazidime, very close to that reported previously (4) was somewhat longer than that of cefamandole. Protein binding of cefamandole (74%) (2) was greater than that of ceftazidime (17%) (4). As measured by relative availability, both penetrated tissue fluid equally well. Previous studies with other ,B-lactams (7) Since serum and tissue fluid levels of ceftazidime exceeded the minimum inhibitory concentration for 90% of the strains of Enterobacteriaceae (6) for 8 h or longer, this agent could possibly be administered twice daily, whereas cefamandole is usually administered three or four times daily, or even more frequently. Even though ceftazidime is relatively less active against Staphylococcus aureus (minimum inhibitory concentration for 90% of strains, 16 ,ug/ml) (6) , the serum and tissue fluid levels were in excess of 16 ,tg/ml for about 3 h, suggesting that therapy directed against this pathogen may be possible if the drug is administered more frequently or in a higher dose.
Previous studies (7) have shown that cantharides blister fluid is similar in composition to superficial burn fluid (5) . The minrimum inhibitory concentration of ceftazidime against 90% of strains of Pseudomonas aeruginosa, 2.0 ,tg/ml (6) , suggests that this agent may be useful in the treatment of burns and tissue infections caused by this pathogen.
